Table 4.
Diseases and affected PLA2 expressions in human patients and in knockout mice.
Types of PLA2 | Expression levels | Diseases | References |
---|---|---|---|
sPLA2-IIA | Highly expressed in synovial fluid | RA | [123,126,165,166,169] |
sPLA2-IIA | Highly expressed in chondrocytes | RA | [126] |
sPLA2-IID | Overexpressed in synovial fluid | RA | [124] |
sPLA2-IIE | Overexpressed in synovial fluid | RA | [124] |
sPLA2-V | Overexpressed in synovial fluid | RA | [124] |
sPLA2-X | More or less expressed in synovial fluid | Active and inactive RA | [124] |
sPLA2-IIA | Overexpressed in synovial fluid | OA | [126,167,168] |
sPLA2-IIA | Overexpressed in VSMC | Infarctus heart | [164] |
sPLA2-V | Overexpressed in VSMC | Infarctus Heart | [164] |
cPLA2-α | cPLA2-α−/− mice loss in function | Prevention in collagen-induced arthritis | [174] |
iPLA2β | iPLA2-β−/− mice loss in function | Low bone mass | [121] |